Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niuhuang Qingwei Wan is a traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is an approved formulation used to clear stomach fire, a TCM concept associated with internal heat and inflammation in the digestive tract and oral cavity. The medicine is indicated for the relief of symptoms such as mouth ulcers, swollen and painful gums, toothache, sore throat, dizziness, and constipation. The formula is a complex combination of 17 herbal and animal-derived ingredients, including Calculus Bovis (Niuhuang), Rhubarb (Dahuang), and Scutellaria (Huangqin), which collectively exert anti-inflammatory, analgesic, and laxative effects. It is typically administered orally in the form of water-honeyed pills or large honeyed pills.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niuhuang qingwei wan.